QLGN QUALIGEN THERAPEUTICS INC Management Changes 8-K Filing 2023 - Resignation of Officer Amy Broidrick, President and Chief Strategy and Operating Officer of Qualigen Therapeutics, Inc., has resigned effective June 16, 2023.Get access to all SEC 8-K filings of the QUALIGEN THERAPEUTICS INC